Position history for Connor, Clark & Lunn Investment Management Ltd.'s holdings in KINIKSA PHARMACEUTICALS INTL
Connor, Clark & Lunn Investment Management Ltd. holds 649,629 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $31.3M as of 2026-Q1. The position was decreased (-12.1% shares). KNSA represents 0.1% of Connor, Clark & Lunn Investment Management Ltd.'s portfolio.
Current Value
$31.3M
Current Shares
649,629
Total Value Change
+$27M
Total Shares Change
+418,550
Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC
Decreased |
| 649,629 |
-12.1% |
| $31.3M |
| 0.1% |
| $45.37 |
0 |
| 2025-Q4 | Increased | 739,326 | +1.9% | $30.5M | 0.1% | $40.99 | 29 |
| 2025-Q3 | Increased | 725,355 | +16.3% | $28.2M | 0.1% | $38.77 | 33 |
| 2025-Q2 | Increased | 623,689 | +56.0% | $17.3M | 0.1% | $28.04 | 40 |
| 2025-Q1 | Increased | 399,743 | +30.2% | $8.9M | 0.0% | $23.09 | 35 |
| 2024-Q4 | Decreased | 306,946 | -5.3% | $6.1M | 0.0% | $19.60 | 0 |
| 2024-Q3 | Increased | 324,064 | +40.2% | $8.1M | 0.0% | $25.00 | 36 |
| 2024-Q2 | New | 231,079 | - | $4.3M | 0.0% | $18.67 | 37 |